Baveno VI criteria as a prognostic factor for clinical complications in patients with compensated cirrhosis

References

1. • de Franchis R.
   • Faculty B.V.
   Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension.
   J Hepatol. 2010; 53: 762-768https://doi.org/10.1016/j.jhep.2010.06.004
   View in Article

   • Google Scholar
2. • D’Amico G.
   • Garcia-Tsao G.
   • Pagliaro L.
   Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.
   J Hepatol. 2006; 44: 217-231https://doi.org/10.1016/j.jhep.2005.10.013
   View in Article

   • Google Scholar
3. • Garcia-Tsao G.
   Preventing the development of varices in cirrhosis.
   J Clin Gastroenterol. 2007; 41 Suppl 3: S300-S304https://doi.org/10.1097/MCG.0b013e318157c63d
   View in Article

   • Google Scholar
4. • Zipprich A.
   • Garcia-Tsao G.
   • Rogowski S.
   • Fleig W.E.
   • Seufferlein T.
   • Dollinger M.M.
   Prognostic indicators of survival in patients with compensated and decompensated cirrhosis.
   Liver Int. 2012; 32: 1407-1414https://doi.org/10.1111/j.1478-3231.2012.02830.x
   View in Article

   • Google Scholar
5. • D'Amico G.
   • Pasta L.
   • Morabito A.
   • D'Amico M.
   • Caltagirone M.
   • Malizia G.
   • et al.
   Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients.
   Aliment Pharmacol Ther. 2014; 39: 1180-1193https://doi.org/10.1111/apt.12721
   View in Article

   • Google Scholar
6. • de Franchis R.
   Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension.
   J Hepatol. 2000; 33: 846-852https://doi.org/10.1016/s0168-8278(00)80320-7
   View in Article

   • Google Scholar
7. • Kovalak M.
   • Lake J.
   • Mattek N.
   • Eisen G.
   • Lieberman D.
   • Zaman A.
   Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database.
   Gastrointest Endosc. 2007; 65: 82-88https://doi.org/10.1016/j.gie.2006.08.023
   View in Article

   • Google Scholar
8. • Berzigotti A.
   Advances and challenges in cirrhosis and portal hypertension.
   BMC Med. 2017; 15: 200https://doi.org/10.1186/s12916-017-0966-6
   View in Article

   • Google Scholar
9. • Thabut D.
   • Trabut J.-B.
   • Massard J.
   • Rudler M.
   • Muntenau M.
   • Messous D.
   • et al.
   Non-invasive diagnosis of large oesophageal varices with FibroTest in patients with cirrhosis: a preliminary retrospective study.
   Liver Int. 2006; 26: 271-278https://doi.org/10.1111/j.1478-3231.2005.01227.x
   View in Article

   • Google Scholar
10. • Bureau C.
    • Metivier S.
    • Peron J.M.
    • Selves J.
    • Robic M.A.
    • Gourraud P.A.
    • et al.
    Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease.
    Aliment Pharmacol Ther. 2008; 27: 1261-1268https://doi.org/10.1111/j.1365-2036.2008.03701.x
    View in Article

    • Google Scholar
11. • Garcia-Tsao G.
    • Friedman S.
    • Iredale J.
    • Pinzani M.
    Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis.
    Hepatology. 2010; 51: 1445-1449https://doi.org/10.1002/hep.23478
    View in Article

    • Google Scholar
12. • Berzigotti A.
    • Seijo S.
    • Arena U.
    • Abraldes J.G.
    • Vizzutti F.
    • García-Pagán J.C.
    • et al.
    Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis.
    Gastroenterology. 2013; 144 (e1): 102-111https://doi.org/10.1053/j.gastro.2012.10.001
    View in Article

    • Google Scholar
13. • Poynard T.
    • Ratziu V.
    • Munteanu M.
    Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection.
    Ann Intern Med. 2013; 159: 370-371https://doi.org/10.7326/0003-4819-159-5-201309030-00019
    View in Article

    • Google Scholar
14. • Abraldes J.G.
    • Bureau C.
    • Stefanescu H.
    • Augustin S.
    • Ney M.
    • Blasco H.
    • et al.
    Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: the “Anticipate” study.
    Hepatology. 2016; 64: 2173-2184https://doi.org/10.1002/hep.28824
    View in Article

    • Google Scholar
15. • de Franchis R.
    • Krag A.
    Ruling out esophageal varices in NAFLD cirrhosis: can we do without endoscopy?.
    J. Hepatol. 2018; 69: 769-771https://doi.org/10.1016/j.jhep.2018.06.013
    View in Article

    • Google Scholar
16. • de Franchis R.
    • Faculty B.V.I.
    Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension.
    J Hepatol. 2015; 63: 743-752https://doi.org/10.1016/j.jhep.2015.05.022
    View in Article

    • Google Scholar
17. • Maurice J.B.
    • Brodkin E.
    • Arnold F.
    • Navaratnam A.
    • Paine H.
    • Khawar S.
    • et al.
    Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices.
    J Hepatol. 2016; 65: 899-905https://doi.org/10.1016/j.jhep.2016.06.021
    View in Article

    • Google Scholar
18. • Jangouk P.
    • Turco L.
    • De Oliveira A.
    • Schepis F.
    • Villa E.
    • Garcia-Tsao G.
    Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis.
    Liver Int. 2017; 37: 1177-1183https://doi.org/10.1111/liv.13379
    View in Article

    • Google Scholar
19. • Llop E.
    • Lopez M.
    • de la Revilla J.
    • Fernandez N.
    • Trapero M.
    • Hernandez M.
    • et al.
    Validation of noninvasive methods to predict the presence of gastroesophageal varices in a cohort of patients with compensated advanced chronic liver disease: validation of noninvasive methods.
    J Gastroenterol Hepatol. 2017; 32: 1867-1872https://doi.org/10.1111/jgh.13781
    View in Article

    • Google Scholar
20. • Bae J.
    • Sinn D.H.
    • Kang W.
    • Gwak G.-Y.
    • Choi M.S.
    • Paik Y.-H.
    • et al.
    Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy.
    Liver Int. 2018; 38: 1442-1448https://doi.org/10.1111/liv.13732
    View in Article

    • Google Scholar
21. • Petta S.
    • Sebastiani G.
    • Bugianesi E.
    • Viganò M.
    • Wong V.W.-S.
    • Berzigotti A.
    • et al.
    Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.
    J Hepatol. 2018; 69: 878-885https://doi.org/10.1016/j.jhep.2018.05.019
    View in Article

    • Google Scholar
22. • Thabut D.
    • Bureau C.
    • Layese R.
    • Bourcier V.
    • Hammouche M.
    • Cagnot C.
    • et al.
    Validation of Baveno VI criteria for screening and surveillance of esophageal varices in patients with compensated cirrhosis and a sustained response to antiviral therapy.
    Gastroenterology. 2019; 156 (e5): 997-1009https://doi.org/10.1053/j.gastro.2018.11.053
    View in Article

    • Google Scholar
23. • Stafylidou M.
    • Paschos P.
    • Katsoula A.
    • Malandris K.
    • Ioakim K.
    • Bekiari E.
    • et al.
    Performance of Baveno VI and expanded Baveno VI criteria for excluding high-risk varices in patients with chronic liver diseases: a systematic review and meta-analysis.
    Clin Gastroenterol Hepatol. 2019; 17 (e11): 1744-1755https://doi.org/10.1016/j.cgh.2019.04.062
    View in Article

    • Google Scholar
24. • Augustin S.
    • Pons M.
    • Maurice J.B.
    • Bureau C.
    • Stefanescu H.
    • Ney M.
    • et al.
    Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease.
    Hepatology. 2017; 66: 1980-1988https://doi.org/10.1002/hep.29363
    View in Article

    • Google Scholar
25. • Nawalerspanya S.
    • Sripongpun P.
    • Chamroonkul N.
    • Kongkamol C.
    • Piratvisuth T.
    Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies.
    Ann Hepatol. 2019; https://doi.org/10.1016/j.aohep.2019.08.005
    View in Article

    • Google Scholar
26. • Gaete M.I.
    • Díaz L.A.
    • Arenas A.
    • González K.
    • Cattaneo M.
    • Fuster F.
    • et al.
    Baveno VI and Expanded Baveno VI criteria succesfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort.
    Liver Int. 2020; https://doi.org/10.1111/liv.14373
    View in Article

    • Google Scholar
27. • Villanueva C.
    • Graupera I.
    • Aracil C.
    • Alvarado E.
    • Miñana J.
    • Puente Á.
    • et al.
    A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis.
    Hepatology. 2017; 65: 1693-1707https://doi.org/10.1002/hep.29056
    View in Article

    • Google Scholar
28. • Qi X.
    • Berzigotti A.
    • Cardenas A.
    • Sarin S.K.
    Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension.
    Lancet Gastroenterol Hepatol. 2018; 3: 708-719https://doi.org/10.1016/S2468-1253(18)30232-2
    View in Article

    • Google Scholar
29. • Goff D.C.
    • Lloyd-Jones D.M.
    • Bennett G.
    • Coady S.
    • D’Agostino R.B.
    • Gibbons R.
    • et al.
    2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
    Circulation. 2014; 129: S49-S73https://doi.org/10.1161/01.cir.0000437741.48606.98
    View in Article

    • Google Scholar
30. • Wang J.-H.
    • Chuah S.-K.
    • Lu S.-N.
    • Hung C.-H.
    • Kuo C.-M.
    • Tai W.-C.
    • et al.
    Baseline and serial liver stiffness measurement in prediction of portal hypertension progression for patients with compensated cirrhosis.
    Liver Int. 2014; 34: 1340-1348https://doi.org/10.1111/liv.12525
    View in Article

    • Google Scholar
31. • Trebicka J.
    • Gu W.
    • de Ledinghen V.
    • Aubé C.
    • Krag A.
    • Praktiknjo M.
    • et al.
    Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease.
    Gut. 2021; https://doi.org/10.1136/gutjnl-2020-323419
    View in Article

    • Google Scholar
32. • Villanueva C.
    • Albillos A.
    • Genescà J.
    • Garcia-Pagan J.C.
    • Calleja J.L.
    • Aracil C.
    • et al.
    β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.
    Lancet. 2019; 393: 1597-1608https://doi.org/10.1016/S0140-6736(18)31875-0
    View in Article

    • Google Scholar
33. • Ripoll C.
    • Groszmann R.J.
    • Garcia-Tsao G.
    • Bosch J.
    • Grace N.
    • Burroughs A.
    • et al.
    Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis.
    J Hepatol. 2009; 50: 923-928https://doi.org/10.1016/j.jhep.2009.01.014
    View in Article

    • Google Scholar
34. • Seeger C.
    • Mason W.S.
    Molecular biology of hepatitis B virus infection.
    Virology. 2015; 479–480: 672-686https://doi.org/10.1016/j.virol.2015.02.031
    View in Article

    • Google Scholar
35. • Praktiknjo M.
    • Simón-Talero M.
    • Römer J.
    • Roccarina D.
    • Martínez J.
    • Lampichler K.
    • et al.
    Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.
    J Hepatol. 2020; 72: 1140-1150https://doi.org/10.1016/j.jhep.2019.12.021
    View in Article

    • Google Scholar
36. • Monteiro S.
    • Grandt J.
    • Uschner F.E.
    • Kimer N.
    • Madsen J.L.
    • Schierwagen R.
    • et al.
    Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation.
    Gut. 2021; 70: 379-387https://doi.org/10.1136/gutjnl-2019-320170
    View in Article

    • Google Scholar
37. • Elkrief L.
    • Lazareth M.
    • Chevret S.
    • Paradis V.
    • Magaz M.
    • Blaise L.
    • et al.
    Liver stiffness by transient elastography to detect porto-sinusoidal vascular liver disease with portal hypertension.
    Hepatology. 2020; https://doi.org/10.1002/hep.31688
    View in Article

    • Google Scholar
38. • Moctezuma-Velazquez C.
    • Saffioti F.
    • Tasayco-Huaman S.
    • Casu S.
    • Mason A.
    • Roccarina D.
    • et al.
    Non-invasive prediction of high-risk varices in patients with primary biliary cholangitis and primary sclerosing cholangitis.
    Am J Gastroenterol. 2019; 114: 446-452https://doi.org/10.1038/s41395-018-0265-7
    View in Article

    • Google Scholar